News | March 06, 2022
Evonik expands production of plant-derived cholesterol in Germany
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Subscribe To Our Newsletter & Stay Updated
